Some cell cycle regulators have been reported to be involved in not only breast cancer progression but also in the stem-like cell activity of breast cancer cells; for example, inhibition of cyclin D1 or CDK4/6 increases or decreases the migration capacity of stem cells in breast cancer [18]. The gene discussed is CDK4; the disease is breast carcinoma.